Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

766
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
766
Protein Networks02:26

Protein Networks

4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BMPR2 Dosage Gates BMP9/10 Signaling Output in Pulmonary Artery Endothelium.

Cells·2026
Same author

CryoEM structure of ALK2:BMP6 reveals distinct mechanism that allow ALK2 to interact with both BMP and activin ligands.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Cripto-1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains.

Protein science : a publication of the Protein Society·2025
Same author

How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva.

Biomolecules·2024
Same author

Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.

Nature communications·2022

Related Experiment Video

Updated: Mar 18, 2026

Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry
08:07

Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry

Published on: January 17, 2025

2.4K

Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis.

Senem Aykul1, Erik Martinez-Hackert1

  • 1Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, 48824-1319, USA.

Analytical Biochemistry
|July 2, 2016
PubMed
Summary

Surface plasmon resonance accurately determines drug potency (IC50) at the molecular level. This method offers higher resolution than cell-based assays, distinguishing specific inhibitor interactions for improved drug discovery.

Keywords:
BMP-4Bone morphogenetic proteinCerberusIC(50)InhibitorSPRSurface plasmon resonanceTGF-β

More Related Videos

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

30.5K
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

21.6K

Related Experiment Videos

Last Updated: Mar 18, 2026

Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry
08:07

Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry

Published on: January 17, 2025

2.4K
Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

30.5K
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

21.6K

Area of Science:

  • Pharmacology
  • Biochemistry
  • Molecular Biology

Background:

  • Half-maximal inhibitory concentration (IC50) is a key metric for drug efficacy and potency.
  • Current methods often rely on whole cell assays, which can be limited by cell line variability and lack of specificity.
  • Differentiating inhibitors targeting specific interactions is crucial for understanding drug mechanisms.

Purpose of the Study:

  • To demonstrate the utility of surface plasmon resonance (SPR) for determining IC50 values.
  • To showcase SPR's capability in resolving individual ligand-receptor interactions.
  • To highlight SPR's advantage over traditional cell-based assays for drug potency determination.

Main Methods:

  • Utilized surface plasmon resonance (SPR) to measure interactions between BMP-4 (a TGF-β family ligand) and its receptors.
  • Determined IC50 values for inhibitors targeting specific BMP-4 and receptor pairings.
  • Compared SPR-based IC50 determination with conventional cell-based assay results.

Main Results:

  • SPR accurately determined IC50 values for individual BMP-4/receptor interactions.
  • The molecular resolution of SPR allowed for clear distinction between inhibitors targeting specific complexes.
  • SPR demonstrated the potential to identify compounds inhibiting multiple interactions simultaneously.

Conclusions:

  • Surface plasmon resonance provides a powerful, high-resolution method for determining drug IC50 values.
  • SPR enhances the understanding of drug potency by resolving specific ligand-receptor interactions.
  • This approach offers advantages over cell-based assays for characterizing inhibitor specificity and mechanism of action.